CareFusion Corp (CFN)

CFN (NYSE:Health Services)
pos +0.25
Today's Range: 58.67 - 58.97 | CFN Avg Daily Volume: 3,584,400
Last Update: 12/17/14 - 4:02 PM EST
Volume: 2,916,334
YTD Performance: 47.29%
Open: $58.73
Previous Close: $58.65
52 Week Range: $37.61 - $59.42
Oustanding Shares: 203,918,151
Market Cap: 11,974,073,827
6-Month Chart
TheStreet Ratings Grade for CFN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 0 0 2 5
Moderate Buy 0 0 0 0
Hold 8 9 7 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3.00 3.00 2.56 2.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 29.81
Price Earnings Comparisons:
CFN Sector Avg. S&P 500
29.81 29.90 24.99
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
26.13% 48.52% 143.77%
Revenue 8.20 0.09 0.03
Net Income 8.30 0.43 0.13
EPS 14.00 0.83 0.22
Earnings for CFN:
Revenue 3.84B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (06/15) FY (06/16)
Average Estimate $0.79 $0.70 $2.86 $2.91
Number of Analysts 8 7 7 8
High Estimate $0.88 $0.75 $2.90 $3.05
Low Estimate $0.64 $0.67 $2.83 $2.79
Prior Year $0.54 $0.60 $2.36 $2.86
Growth Rate (Year over Year) 46.53% 15.95% 21.31% 1.56%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
There may be a wave of consolidation.
The market is rewarding HP's breakup. Here's why.
Hewlett-Packard's recent spin-off is a good idea.
May 06, 2014 | 7:57 AM EDT
CFN lowered its number, Barclays said. Lighter revenue driven by weakness in the Medical Systems segment. $42 price target and Equal We...
Dec 17, 2013 | 8:03 AM EST
CFN was downgraded from Neutral to Sell, Goldman Sachs said. Valuation call, based on a $36 price target. 
Aug 29, 2013 | 7:40 AM EDT
CFN price target was boosted to $42 from $37 as margin expansion should lead to multiple expansion, said Citigroup.
Sep 07, 2012 | 7:55 AM EDT
Coverage of CFN was started with a Buy rating, ThinkEquity said. $30 price target. Company can continue to deliver solid organic growth...

CareFusion Is Cruising Real Money Pro($)

Expect the medical instrument supplier to reach new 2012 highs in the near term.
May 24, 2012 | 7:49 AM EDT
CFN was upgraded from Outperform to Buy, Credit Suisse said. Expect strong 2013 guidance from management. $30 price target. 
Feb 17, 2012 | 7:47 AM EST
CFN was upgraded from Market Perform to Outperform, Morgan Keegan said. $31 price target. Company can expand margins over the coming qu...

Columnist Conversations

AAPL needs to clear this hurdle IF this last low is any good!! View Chart » ...
The Fed didn't raise interest rates, but the market did via lower bond and note prices. The recent run in Trea...
WHR has regained all the of the ground lost over the last nine sessions during today's rip higher. The st...
Just to let you know, the three dissents come from governors who will not be voting members in 2015. Fisher i...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.